Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Development of an early warning system for progression in non-muscle invasive bladder cancer patients using time-series forecasting with artificial intelligence

FY 2021-22

Summary
Bladder cancer is the 5th most common cancer in Canada with about 75% of these patients being diagnosed with non-muscle invasive bladder cancer (NMIBC), in which the tumour does not infiltrate the muscle layer surrounding the bladder. NMIBC has about a 65% recurrence rate but unfortunately, up to 20% of NMIBC patients will progress to more advanced stages of disease. While NMIBC can be managed with minimally invasive surgeries to remove bladder tumours or instilling medication into the bladder, higher stages such as muscle invasive bladder cancer requires extensive surgery which includes the removal of the bladder, nearby organs, and the need to create a urinary diversion to allow urine to drain from the kidneys to outside the body.As progression often occurs after multiple NMIBC recurrences, identifying patients at risk of progression is important for both patient counselling and clinical decision-making to guide frequency of follow-ups and the need for more aggressive upfront treatment. Unfortunately, current predictive models are limited due to poor performance and several practical issues. First, these models do not reflect the current standard of care for management of NMIBC, which includes re-resection of the tumour bed when indicated and use of intravesical therapies. Second, these models are time-fixed in that they do not capture changes in the patient's cancer status after initial diagnosis, which includes subsequent follow-ups and tumour recurrences. To address these shortcomings, we plan to develop a time-series forecasting model using artificial intelligence to better encapsulate the complete oncological timeline of contemporarily treated NMIBC patients to improve prognostic accuracy.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466620
Name
Kwong Jethro C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of an early warning system for progression in non-muscle invasive bladder cancer patients using time-series forecasting with artificial intelligence
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Artificial Intelligence; Bladder Cancer; Early Warning System; Forecasting; Machine Learning; Non-Muscle Invasive Bladder Cancer; Progression
Abstract
Bladder cancer is the 5th most common cancer in Canada with about 75% of these patients being diagnosed with non-muscle invasive bladder cancer (NMIBC), in which the tumour does not infiltrate the muscle layer surrounding the bladder. NMIBC has about a 65% recurrence rate but unfortunately, up to 20% of NMIBC patients will progress to more advanced stages of disease. While NMIBC can be managed with minimally invasive surgeries to remove bladder tumours or instilling medication into the bladder, higher stages such as muscle invasive bladder cancer requires extensive surgery which includes the removal of the bladder, nearby organs, and the need to create a urinary diversion to allow urine to drain from the kidneys to outside the body.As progression often occurs after multiple NMIBC recurrences, identifying patients at risk of progression is important for both patient counselling and clinical decision-making to guide frequency of follow-ups and the need for more aggressive upfront treatment. Unfortunately, current predictive models are limited due to poor performance and several practical issues. First, these models do not reflect the current standard of care for management of NMIBC, which includes re-resection of the tumour bed when indicated and use of intravesical therapies. Second, these models are time-fixed in that they do not capture changes in the patient's cancer status after initial diagnosis, which includes subsequent follow-ups and tumour recurrences. To address these shortcomings, we plan to develop a time-series forecasting model using artificial intelligence to better encapsulate the complete oncological timeline of contemporarily treated NMIBC patients to improve prognostic accuracy.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwong, Jethro C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~